System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Clarisse Eveno is an expert in Surgery at Hôpital Claude Huriez (France). Clarisse Eveno has authored 304 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 5 of them ongoing. SLR score: 890 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Clarisse Eveno Hôpital Claude Huriez France
890 ScienceLeadR Reputation 890

Unlock

Register Login
Network Map

Surgery

Subspecialties: Oncology - Public Health - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026
Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 304

Citations

Citations: 4 903 1st author: 39 Last author: 42 Unique author: 1

Main journals

Eur J Surg Oncol 44
Ann Surg Oncol 37
J Visc Surg 18
Journal de chirurgie viscérale 16
Journal de Chirurgie Viscérale 14

Best Journals

J Clin Oncol 3
Lancet Oncol 2
Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparison of surgical and oncological outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in upper and middle/lower rectal peritoneal metastases.
PMID 42648158 — cytoreduction surgical procedures, hyperthermia, induced, hyperthermic intraperitoneal chemotherapy, drug therapy, neoplasm metastasis, risk factors, chemotherapy		Surg Oncol20260
Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries.
PMID 42483900 — global health, emergencies, surgical procedures, operative, neoplasms, income, cohort studies, colorectal neoplasms		BJS Open20260
International practice patterns and perceptions of pressurised intraperitoneal aerosol chemotherapy for management of gastric cancer: A global clinician survey.
PMID 42173034 — aerosols, neoplasms, perception, drug therapy, therapeutics, stomach neoplasms, chemotherapy		Eur J Surg Oncol20260
Thromboprophylaxis, pain and organization: How do expert centers manage PIPAC's perioperative care? An international survey.
PMID 42143535 — pain, perioperative care, biological monitoring, environmental monitoring, pressurized intraperitoneal aerosol chemotherapy		Eur J Surg Oncol20260
The effect of delays in cancer surgery due to the COVID-19 pandemic on cancer resectability and postoperative mortality in different tumor entities.
PMID 42104020 — mortality, neoplasms, covid-19, pandemics		Discov Oncol20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 5
Phase 2 3
Phase 3 3
Phase 1 1

By status:

Unknown 5
Recruiting 3
Not yet recruiting 2
Active not recruiting 1
Completed 1

By type:

Interventional 7
Observational 5

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 2
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 15

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Systemic antitumor treatment with or without pressurized intraperitoneal aerosol chemotherapy (PIPAC) for colon peritoneal metastases a multicentre phase II randomized trial (PIPOX02)
2024-514560-10-00 — aerosols, neoplasms, colon, drug therapy, neoplasm metastasis, therapeutics, chemotherapy, pressurized intraperitoneal aerosol chemotherapy		Phase 2Recruiting2025
Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)
NCT06681038 — surgical oncology, vascular endothelial growth factor a, progression-free survival, aerosols, neoplasms, colon, drug therapy, oxaliplatin, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy, pressurized intraperitoneal aerosol chemotherapy		Phase 2Not yet recruiting2025
The Efficacy of PIPAC and Minimally Invasive Radical Resection in High risk Gastric Cancer Patients
NCT06295094 — stomach, minimally invasive surgical procedures, aerosols, surgical procedures, operative, doxorubicin, neoplasms, drug therapy, neoplasm metastasis, chemotherapy, adjuvant, gastrectomy, stomach neoplasms, chemotherapy, pressurized intraperitoneal aerosol chemotherapy		Phase 2Not yet recruiting2024
Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
NCT06107920 — colostomy, neoplasms, colon, drug therapy, chemotherapy, adjuvant, neoadjuvant therapy, therapeutics, colectomy, colonic neoplasms, chemotherapy		Phase 3Recruiting2024
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer
NCT04811703 — safety, cytoreduction surgical procedures, paclitaxel, aerosols, fallopian tube neoplasms, ovary, doxorubicin, neoplasms, drug therapy, ovarian neoplasms, peritoneal neoplasms, therapeutics, carboplatin, ca-125 antigen, carcinoma, ovarian epithelial, peritoneum, fallopian tubes, chemotherapy, carcinoma, pressurized intraperitoneal aerosol chemotherapy, women		Phase 1Recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS